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Abstract.  O-2A progenitor  cells give rise to both 
oligodendrocytes and type-2 astrocytes in vitro. 
Whereas  oligodendrocyte differentiation  occurs consti- 
tutively,  type-2 astrocyte differentiation  requires  ex- 
tracellular  signals,  one of which is thought to be 
ciliary  neurotrophic  factor (CNTF).  CNTF,  however, 
is insufficient by itself to induce the development of 
stable type-2 astrocytes.  In this  report we show the 
following:  (a) that molecules associated with the ex- 
tracellular  matrix  (ECM) cooperate with CNTF to in- 
duce stable type-2 astrocyte differentiation  in serum- 
free cultures.  The combination  of CNTF and the 
ECM-associated  molecules thus  mimics the effect of 
FCS,  which has been shown previously to induce sta- 
ble type-2 astrocyte differentiation  in vitro.  (b) Both 
the ECM-associated  molecules and  CNTF act directly 
on O-2A progenitor  cells and can induce them to 
differentiate prematurely  into type-2 astrocytes.  (c) 
ECM-associated  molecules also inhibit oligodendro- 
cyte differentiation,  even in the absence of CNTF, but 
this inhibition  is not sufficient on its own to induce 
type-2 astrocyte differentiation.  (d) Whereas  the effect 
of ECM  on oligodendrocyte differentiation  is mim- 
icked by basic fibroblast growth factor (bFGF),  the 
effect of ECM  on type-2 astrocyte differentiation  is 
not.  (e) The ECM-associated  molecules that are 
responsible for inhibiting  oligodendrocyte differentia- 
tion and for cooperating  with CNTF to induce type-2 
astrocyte differentiation  are made by non-glial  cells in 
vitro.  (f)  Molecules that have these activities and bind 
to ECM are present in the optic nerve at the time 
type-2 astrocytes are thought to be developing. 
T 
HE vertebrate central  nervous system (CNS) ~ devel- 
ops from the neuroepithelial cells that form the neural 
tube. These ceils give rise to a spectacular diversity 
of nerve cells, as well as to various kinds of supporting (glial) 
cells. The generation of diverse cell types at specific times 
and locations is thought to depend on interactions between 
cells, although little is known about the nature of the signals 
that presumably mediate these interactions. 
To begin to analyze these signals, we have studied the de- 
velopment of a bipotential glial progenitor cell found in the 
rat CNS. It is called the O-2A progenitor cell because it can 
differentiate in vitro into either an oligodendrocyte, which 
makes myelin in the CNS, or a type-2 astrocyte, whose func- 
tions  are  uncertain  (reviewed  in  Raft,  1989).  Studies  in 
which antibodies were used to distinguish glial cell types in 
cell suspensions prepared from rat brain and optic nerve at 
different ages suggest that O-2A progenitor cells differentiate 
in vivo on a characteristic schedule, giving rise to oligoden- 
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1.  Abbreviations  used in  this paper:  CNTE  ciliary neurotrophic factor; 
ECM, extracellular matrix; GC, galactocerebroside; GFAP, glial fibrillary 
acidic protein; SF-DME, serum-free Dulbecco's modified Eagle's medium. 
drocytes beginning at the time of birth and to type-2 astro- 
cytes beginning in the second postnatal week (Abney et al., 
1981;  Miller et al.,  1985; Williams et al.,  1985). This de- 
velopmental  sequence  can  be  reproduced  in  cultures  of 
perinatal  rat  brain  (Williams  et al.,  1985;  Lillien  et  al., 
1988) or optic nerve cells (Lillien and Raft,  1990).  These 
cultures,  therefore,  provide experimentally  accessible sys- 
tems to analyze the environmental  signals that control the 
differentiation  of O-2A progenitor  ceils.  Cultures of optic 
nerve cells are especially advantageous because they do not 
contain neurons; in addition to O-2A lineage cells (oligoden- 
drocytes, type-2 astrocytes, and O-2A progenitor ceUs), they 
contain  several  types  of non-O-2A  lineage  cells,  mainly 
type-1  astrocytes,  meningeal  cells,  macrophages,  and  en- 
dothelial cells. 
The differentiation of O-2A progenitor cells into oligoden- 
drocytes is thought to be the default pathway of development, 
which is triggered automatically when the progenitor cells 
stop dividing  (reviewed in  Raft,  1989).  O-2A progenitor 
cells are stimulated to proliferate in vitro by PDGF (Noble 
et al.,  1988), which is secreted by type-1 astrocytes (Rich- 
ardson et al., 1988), the first glial cells to develop in the optic 
nerve (Miller  et al.,  1985).  In the absence of PDGF and 
other environmental  signals, progenitor cells stop dividing 
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cytes (Temple and Raft, 1985; Raff et al., 1988). Even in the 
presence of PDGF, however, O-2A progenitor cells divide 
only a limited  number of times before an intrinsic  timing 
mechanism  in the ceils causes them to stop dividing  and 
differentiate into oligodendrocytes (Raft et al.,  1988). 
In contrast to oligodendrocyte development, the differenti- 
ation of O-2A progenitor cells into type-2 astrocytes in vitro 
requires signals made by other types of cells. If an enriched 
population of O-2A progenitor cells is cultured in PDGF in 
the absence of serum,  for example,  oligodendrocytes de- 
velop, but type-2 astrocytes do not unless non-O-2A lineage 
cells are added (Lillien and Raft,  1990); the non-O-2A lin- 
eage cells presumably provide the required type-2 astrocyte- 
inducing signals. There is evidence that one of these induc- 
ing  signals  is CNTF,  a  23-kD protein  (Manthorpe  et al., 
1986), which is made in vitro by type-1 astrocytes (Hughes 
et al.,  1988; Lillien et al.,  1988). The onset of type-2 astro- 
cyte development seems to be regulated, at least in part, by 
the timed production and release of ciliary neurotrophic fac- 
tor (CNTF), rather than by the onset of progenitor cell re- 
sponsiveness to it (Hughes et al., 1988; Lillien et al., 1988). 
CNTF is not sufficient on its own, however, to induce the de- 
velopment of stable type-2 astrocytes: when O-2A progeni- 
tor ceils are exposed in vitro to CNTF (Hughes et al., 1988), 
or to extracts of brain cultures (Lillien et al.,  1988) or optic 
nerves (Hughes and Raft,  1987) that contain  CNTF (or a 
CNTF-like protein),  they are induced to express the astro- 
cyte-specific molecule glial fibrillary acidic protein (GFAP; 
Bignami et al., 1972), but only transiently. This observation 
suggests that additional  signals,  perhaps  nondiffusible,  are 
required for stable type-2 astrocyte development. 
We recently reported that stable type-2 astrocytes develop 
in serum-free cultures of newborn optic nerve cells, begin- 
ning  •1  wk after the first oligodendrocytes develop, pro- 
vided that PDGF is added to the cultures (Lillien and Raft, 
1990). Thus all of the environmental signals required for sta- 
ble type-2 astrocyte development must be present in these 
cultures. In the present study we have used these cultures to 
characterize the signals that, in addition to CNTF, are neces- 
sary for type-2 astrocyte development. 
Materials and Methods 
Cell Cultures Used  for Preparing ECM 
Newborn optic nerve cells were dissociated from Sprague-Dawley rats and 
cultured on 13-mm poly-D-lysine (PDL)-coated glass coverslips for 3-15 d 
in serum-free, hormone-supplemented Dulbecco's modified Eagle's medi- 
um (SF-DME) as previously described (Lillien and Raft, 1990).  In some 
cases the cells were grown in human PDGF (2 ng/ml; R & D Systems, Inc., 
Minneapolis, MN), which was added every 2-3 d. The culture medium was 
changed 1 d after plating, and half the medium was replaced every 3-4 d. 
Cultures of non-O-2A lineage cells were prepared by treating fresh sus- 
pensions of newborn optic nerve cells with mAb A2B5 (Eisenbarth et al., 
1979) and anti-galactocerebroside (GC) antibodies in the presence of rabbit 
complement for 45 min at 370C, as previously described (Lillien and Raft, 
1990).  After washing, ~5,000 cells were cultured in SF-DME for 10 d. No 
O-2A lineage cells (oligodendrocytes or O-2A progenitor cells) were found 
when such cultures were stained for GC and A2B5 as described below. 
Cultures enriched for O-2A lineage cells were prepared by dissociating 
P8 optic nerve cells and culturing ,,o5,000 cells in SF-DME for 10 d. PDGF 
was added to obtain cultures enriched for both O-2A progenitor cells and 
oligodendrocytes, but was omitted to obtain cultures enriched mainly for 
uligodendrocytes. 
Cultures enriched for type4 astrocytes or meningeal cells were prepared 
from the cerebral hemispheres of newborn rats as previously described (Lil- 
lien et al., 1988).  The cells were removed from flasks with trypsin (0.1%) 
and EDTA (0.02 %), and, after washing, "~10,000 cells were plated on PDL- 
coated coverslips in DME containing 10%  FCS. Cells were either main- 
talned in 10% FCS for 10 d or switched to SF-DME 1 d after plating; no 
significant difference was observed in the ECMs prepared from cultures 
grown in the two conditions. 
Cultures of macrophages were prepared from meningeal cell cultures in 
the following way. Flasks of meningeal cells were not fed for 1-2 wk, after 
which time large numbers of macrophages (identified by the presence of 
cell-surface Fc receptors, Raft et al., 1979) appeared on top of the menin- 
geal cell monolayer. The macrophages were removed by shaking the flask, 
and 10,000 of them were cultured on PDL-coated coverslips in SF-DME 
containing 0.5% FCS. 
Cultures of bovine aortic endothelial cells (kindly provided by M. Noble, 
Ludwig Institute, London, who obtained the cells from L  Fotkman, Har- 
vard Medical School; Vlodavsky et al., 1987) were cultured (after multiple 
passages) on PDL-coated coverslips in DME containing 10% calf serum. 
Half of the medium was replaced with SF-DMEM 1 d after plating and ev- 
ery 3-4 d thereafter. 
Matrigel  was  obtained from Collaborative Research, Inc.  (Waltham, 
MA) and was prepared as a  substratum as described by Stemple et al. 
(1988). 
Preparation of  EC  M 
After the culture medium was aspirated, the cells were removed from the 
coverslips by treatment with 20  mM ammonia containing 0.5%  Triton 
X-100 for 2-3 rain at room temperature, and the coverslips were washed 
in the same solution for another 2-3 min. The ECM was washed twice with 
either 150 mM or 2 M NaC1 (in 2 mM phosphate buffer, pH 7.5) for 30 
rain and then rinsed repeatedly in DME. The ECM was kept at 37°C and 
used within 3-4 h. Similar results were obtained when the cells were re- 
moved with 20 mM ammonia alone. 
Cells Used  for Assaying the Effects of CNTF and ECM 
Because FCS induces type-2 astrocyte differentiation in vitro (Raft et al., 
1983), we performed all of these experiments in serum-free medium. New- 
born and embryonic day 18 (E18) optic nerve cells were dissociated as previ- 
ously described (Rafter al., 1988; Lillien and Raft, 1990), and 3,000-5,000 
cells were cultured in PDGF and/or CNTF (2 ng/ml) in SF-DME, either 
on PDL-coated coverslips or on ECM-coated coverslips. The CNTF was 
purified from rat sciatic nerve as previously described (Stocldi et al., 1989). 
The culture medium was replaced 1 d after plating and fresh PDGF and/or 
CNTF was added. The medium change at 1 d was important because it re- 
moved the endogenous CNTF-like activity that is released by the cultured 
cells during the first day in vitro, presumably in response to the dissociation 
procedure (Lillien et ai.,  1988). 
Cultures enriched for O-2A progenitor cells were prepared from P7-9 
optic nerves after partial removal of the meninges. Approximately 20,000- 
40,000  cells were cultured on PDL-coated 35-ram plastic tissue culture 
dishes (Falcon Labware, Oxnard, CA) in SF-DME containing PDGF and 
bovine brain FGF (10 ng/ml; R &  D). M. Noble and his colleagues have 
observed that this combination of growth factors prevents the differentiation 
of O-2A progenitor cells into oligodendrocytes and keeps them dividing 
(Btgler et al., 1990). Culture medium and growth factors were replaced 1 d 
after plating, and fresh PDGF and bFGF were added every other day. Cells 
were used within 1 wk of plating. They were removed from the culture dish 
with trypsin and EDTA and then washed; 500-1,000 cells were used in each 
assay culture. At the time the cells were used, "~85% were O-2A lineage 
cells, and, of these, 5-20%  were GC  ÷ oligodendrocytes. 
Immunofluorescence 
Cultures were fixed in 4 % paraformaldehyde for 5 rain at room temperature 
and then double- or triple-stained by indirect immunofluorescence  as previ- 
ously described (Lillien et al.,  1988).  Briefly,  for triple labeling, the cells 
were first labeled with anti-GC mAb (ascites fluid,  1:100; Ranscht et al., 
1982) followed by class-specific goat anti-mouse IgG3 coupled to fluores- 
cein (G anti-MIgG3-Fl; Nordic Immunology, Tilburg, The Netherlands; 
1:100),  and then with mAb A2B5 (ascites fluid,  1:100; Eisenbarth et al., 
1979) followed  by G anti-mouse immunoglobulin coupled to rhodamine (G 
anti-MIg-Rd, Cappel Laboratories, Malvern, PA; 1:100); after fixation with 
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gliai fibrillary acidic protein (GFAP) antiserum (1:1,000;  Pruss, 1979) fol- 
lowed by sheep anti-rabbit It-F1 (Sh anti-RIg-Fl; Burroughs Wellcome Co., 
Research Triangle Park, NC; 1:100).  For double labeling, the ceils were la- 
beled with either A2B5 or anti-GC antibody followed by G anti-MIg-I/d and 
then processed for GFAP staining as above. Labeled cultures were examined 
with a Zeiss Universal fluorescence microscope using a 40x objective and 
photographed using Tri-X film (ASA 400). 
Microcultures 
60-well Terasaki plates (Nunc, Roskilde, Denmark) were seeded with either 
newborn optic nerve cells in SF-DME or type-1 astrocytes in DME contain- 
ing 10%  FCS;  1,000 cells were seeded in 10/~1.  ECM was prepared after 
10-14 d as described above. Approximately five enriched O-2A progenitor 
cells were then added to each microwell in 10 #1 of SF-DME, containing 
2 ng/ml CNTF where appropriate. Most microwells contained one to two 
cells. The cells were double-labeled with A2B5 and anti-GFAP antibodies 
and viewed as previously described (Temple and Raft,  1985). 
Preparation  of Optic Nerve Extract in 2 M NaCl 
Extracts of optic nerves from 3-5-wk-old rats were prepared as previously 
described (Hughes and Raft,  1987) except that 2  M  NaC1 was used. The 
extracts were dialyzed extensively against 150 mM NaC1, centrifuged at 
80000 g  for 30 min to remove material that had precipitated,  and then 
stored at  -70"C.  We refer to this extract as 2M-ONE. 
Adsorption of 2M-ONE, CNTF, and bFGF to 
2 M NaCl-treated ECM 
ECM that had been treated with 2 M  NaCI was incubated in DME alone 
or in DME containing 2M-ONE (150-250/,g/ml total protein), CNTF (10 
ng/ml), or bFGF (100 ng/ml) for 3 h at 37°C. The ECM was rinsed in DME 
before enriched O-2A progenitor cells were added. 
Results 
CNTF-treated O-2A Progenitor Cells Express GFAP 
Transiently and Then Become Oligodendrocytes 
As reported previously (Hughes et al.,  1988),  when cells 
from newborn optic nerve were exposed to CNTE 20-30% 
of the O-2A progenitor cells (identified by their characteris- 
tic morphology and staining with the A2B5 mAb; Temple 
and Raft, 1986) began to express GFAP after 1 d in vitro, 
but, by 3 d in vitro, O-2A lineage cells expressing GFAP 
were no longer seen (Table I). After 2 d in vitro, >95 % of 
the GFAP  + O-2A lineage cells in such cultures were found 
to express a mixed oligodendrocyte/type-2 astrocyte pheno- 
type, being GC  + and GFAP  + (Table I). This finding suggests 
that the cells that. are induced by CNTF to express GFAP 
transiently do not die or dedifferentiate into O-2A progenitor 
ceils but instead go on to become oligodendrocytes. 
PDGF  Antagonizes the Transient Effect of CNTF 
We showed previously that stable type-2 astrocytes develop 
in cultures of newborn optic nerve cells grown in serum-free 
medium, but only if PDGF is added to the medium (Lillien 
and Raft, 1990). The requirement for PDGF raised the pos- 
sibility that stable type-2 astrocyte differentiation in culture 
might be induced by a combination of CNTF and PDGE 
When tested directly, however,  the combination of CNTF 
and PDGF did not induce O-2A progenitor cells to differen- 
tiate into stable type-2 astrocytes; instead, PDGF antago- 
nized the ability of CNTF to induce progenitor cells to ex- 
press GFAP transiently (Table I). This suggests that PDGF 
Table I. Signals Required  for Stable vs. Transient 
Type-2 Astrocyte Differentiation 
O-2A lineage cells 
expressing a type-2 astro- 
eyte phenotype (A2B5*, 
GFAP  +) after 
GFAP  + O-2A lineage 
cells expres~g a mixed 
oligodendrocyte/type-2 
astrocyte phenotype 
(GC) after 
Culture treatment  1 d  2 d  3 d  1 d  2 d  3d 
CNTF  22  +2  14  +3  0  5  +  5  96+4  ND 
CNTF  +  PDGF  6  +2  ND  2  +  1  ND  ND  ND 
CNTF  +  ECM  38  +  5  ND  79  +  5  ND  ND  0 
Newborn optic nerve cells were cultured for 1-3 d  and then double-labeled 
with either A2B5 and anti-GFAP or anti-GC and anti-GFAP antibodies. The 
ECM was prepared from 9-12-d-old cultures of newborn optic nerve cells. 
O-2A lineage cells were recognized by their antigenic phenotype (A2B5 +) 
and/or their characteristic process-bearing morphologies. In the absence of 
CNTF and ECM, <1% of the O-2A lineage cells expressed GFAP after I, 2, 
and 3 d in vitro. In this and in Tables II, HI, and V the results are expressed 
as means +  SE of at least three experiments. 
is required for type-2 astrocyte development in serum-free 
cultures of newborn optic nerve cells only because it keeps 
O-2A progenitor ceils proliferating (and thereby prevents 
their premature differentiation into oligodendrocytes) until 
endogenous type-2 astrocyte-inducing signals are produced 
by the cultured cells. 
A  Combination of CNTFand 
ECM-associated Molecules Induces Stable ~ype-2 
Astrocyte Differentiation In Vitro 
Although stable type-2 astrocytes develop after 8-10 d in 
serum-free cultures of newborn optic nerve cells in the pres- 
ence of PDGF (Lillien and Raft,  1990),  supernatants pre- 
pared from these cultures at this time only induce O-2A pro- 
genitor cells in vitro to express GFAP transiently rather than 
to develop into stable type-2 astrocytes (unpublished obser- 
vations). The same is true for supernatants prepared from 
embryonic brain cell cultures (Lillien and Raft, 1988) and 
for saline extracts prepared from such cultures (Lillien et al., 
1988) and from optic nerve (Hughes and Raft, 1987),  all at 
the time type-2 astrocytes are developing. These findings 
suggest that diffusible signals are not sufficient to induce sta- 
ble type-2 astrocyte differentiation. We therefore looked for 
Table I1. O-2A Progenitor Cells Respond Prematurely 
to Type-2 Astrocyte-inducing Signals 
Age of rats  Culture treatment 
O-2A lineage cells 
expressing a type-2 
astrocyte phenotype 
after 3-4 d in vitro 
El8  ECM  +  CNTF  100 
El8  ECM  +  CNTF  +  PDGF  100 
Newborn  ECM  +  CNTF  79  +  5 
Newborn  ECM  +  CNTF  +  PDGF  61  +  3 
Optic nerve cells from newborn or embryonic day 18 (El8) rats were cultured 
on ECM prepared from 10-d-old  cultures of newborn optic nerve cells. The 
cultures were triple-labeled with anti-GC, A2B5, and anti-GFAP antibodies. 
A type-2 astrocyte phenotype was defined as a process-bearing cell that was 
A2B5  + and GFAP  +. 
Lillien et al. ECM-associated Astrocyte-inducing Signals  637 Figure 1. Immunofluorescence micrographs of  type-2 astrocytes induced by CNTF and ECM. Enriched O-2A progenitor cells were cultured 
in CNTF for 6 d on ECM prepared from 14-d-old cultures of newborn optic nerve cells. Cells in two cultures are shown: in one the ceils 
were labeled for A2B5 (a) and GFAP (b); in the other the cells were labeled for GC (c) and GFAP (d). Note that the type-2 astrocytes 
are A2B5  ÷, GFAP  +, and GC-, whereas the GC  ÷ oligodendrocyte shown in c is GFAP- (d). Bar, 25/~m. 
a nondiffusible inducing signal in cultures of newborn optic 
nerve cells grown in vitro for 9-15 d,  a  time when stable 
type-2 astrocytes were found to develop in these cultures 
(Lillien and Raft, 1990). We began by testing the ECM pro- 
duced by these cultures; although we shall follow the conven- 
tional practice of using the term ECM to refer to the material 
left behind on the culture dish after the cells were removed 
with ammonia and Triton X-100, we cannot exclude the pos- 
sibility that the relevant signalling molecules were associated 
with residual cell fragments. 
When cells from newborn optic nerve were cultured in the 
presence of CNTF on ECM prepared from cultures of new- 
born optic nerve cells, the majority of O-2A progenitor cells 
differentiated into  stable,  GC- type-2 astrocytes by 3  d  in 
vitro (Table I). If, instead of CNTF, a saline extract of 3--4- 
wk-old optic nerve (Hughes  and  Raft,  1987)  was used in 
combination with ECM,  similar results were observed (not 
shown). Even after 1 d in vitro, more O-2A lineage cells ex- 
pressed GFAP when they were exposed to both ECM and 
CNTF than when they were exposed to CNTF alone (Table 
I).  When cells from embryonic day  18  (El8)  optic nerves 
were cultured on ECM in the presence of CNTF, all of the 
O-2A progenitors differentiated into type-2 astrocytes by 3 d 
in vitro (Table ID, indicating that O-2A progenitor cells are 
responsive to both CNTF and ECM long before they nor- 
mally differentiate into type-2 astrocytes.  Whereas PDGF 
strongly antagonized the transient effects of CNTF alone (see 
Table I),  it  antagonized  the  effects of the  combination of 
CNTF and ECM only weakly or not at all (Table II). 
CNTF and ECM Act Directly on O-2A Progenitor 
Cells to Induce 1)lpe-2 Astrocyte Development 
To study further the signal associated with the ECM made 
by optic nerve cultures and to identify its cellular source, we 
used an enriched population of O-2A progenitor cells as test 
cells.  These cells were prepared from optic nerve cultures 
that  had  been  maintained  in  the  continuous  presence  of 
PDGF and bFGE For the most part, these enriched O-2A 
progenitor cells responded to CNTF and ECM in the same 
way as O-2A progenitor cells in cultures of perinatal optic 
nerve cells: when cultured on ECM in the presence of CNTF 
for 3 or 6 d,  the majority differentiated into GC-, A2B5  +, 
GFAP  + type-2  astrocytes  (Fig.  1  and  Table HI),  whereas 
when cultured on ECM without CNTF, or in CNTF without 
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to CNTF and ECM 
O-2A lineage cells expressing a 
type-2  astrocyte phenotype after 
Substratum  CNTF  1 d  3 d  6 d 
$ 
PDL  -  0  0  ND 
PDL  +  4  +  1  0  ND 
ECM  -  <1  <1  ND 
ECM  +  42  +  9  63  +6  91  +  1 
Enriched O-2A progenitor cells were cultured  on PDL or on ECM that was 
prepared from 9-12-d-old cultures of newborn optic nerve cells. After 1-6 d, 
the cultures were triple-labeled  as in Table II, or double-labeled  with anti-GO 
and  anti-GFAP antibodies, and type-2  astrocytes were  identified  either as 
A2B5 +,  GFAP  + process-bearing cells, or as Ca2-,  GFAP  + process-bearing 
cells, respectively.  The results  were not significantly  different  with the two 
staining procedures. 
ECM, the cells that differentiated developed into oligoden- 
drocytes and not type-2 astrocytes (Table m; see Fig. 2). The 
enriched O-2A  progenitor cells differed from progenitor 
cells in cultures of  perinatal optic nerve, however, in that few 
of them responded even transiently to CNTF in the absence 
of ECM, although many responded within 24 h to CNTF in 
the presence of ECM (Table III). 
To  determine whether CNTF  and the  ECM-associated 
Table IV. Effect of CNTF and ECM on Single O-2A 
Progenitor Cells 
ECM prepared 
from cultures  of  CNTF 
Fraction of O-2A 
lineage cells 
expressing a 
type-2 astrocyte 
phenotype 
after 3 d 
Optic nerve cells  -  0/42 
Optic nerve cells  +  64/117 
Type-1  astrocytes  +  0/97 
Individual  O-2A progenitor cells were added (by limiting dilution)  to micro- 
wells containing ECM produced by either newborn optic nerve ceils or typed 
astrocytes.  The cells were double-labeled  with A2B5 and anti-GFAP antibod- 
ies. On average, there were 1.5 cells/well;  32 of the wells with optic nerve cell 
ECM contained a single O-2A lineage cell as the only visible cell in the well, 
and 17 of these were GFAI  ~. 
molecules act directly on O-2A progenitor cells, rather than 
indirectly via other cell types, we cultured individual pro- 
genitor cells in microwells for 3 d. As shown in Table IV, 
isolated O-2A progenitor ceils cultured on ECM prepared 
from newborn optic nerve cell cultures developed into type-2 
astrocytes in the presence, but not in the absence, of CNTE 
Thus both CNTF and the ECM-associated molecules act 
directly on O-2A progenitor ceils to induce type-2 astrocyte 
differentiation. 
ECM 
treated 
Substratum  with 
(a)  PDL 
(b)  PDL 
(c)  ON ECM  untreated 
(d)  ON ECM  untreated 
(e)  Meningeal  untreated 
cell ECM 
(f)  Endothelial  untreated 
cell ECM 
(g)  Type- 1  untreated 
astrocyte 
ECM 
(h)  ON ECM  1 M  NaCi 
(i)  ON ECM  2  M  NaCI 
(j)  ON ECM  2  M  NaCi 
(k)  ON ECM  2  M  NaC1 
(1)  PDL 
(m)  Type-1  2  M  NaCI 
astrocyte 
ECM 
(n)  ON ECM  2  M  NaCI 
2  M  NaCI- 
treated 
ECM  Cultured 
incubated  for 3 d 
for 3  h  with  with 
2M-ONE 
2M-ONE 
bFGF 
CNTF 
CNTF 
CNTF 
CNTF 
CNTF 
2M-ONE 
%  O-2A  lineage cells expressing 
GC after 3 d  compared to that 
seen on PDL ~lon¢ 
2s  so  7s  i?o 
i 
iI 
m 
II 
II 
ll 
Figure  2.  ECM-associated  sig- 
nals that inhibit oligodendrocyte 
differentiation.  Enriched  O-2A 
progenitor ceils were cultured on 
PDL or ECM for 3 d and then tri- 
ple-labeled  for  GC,  A2B5,  and 
GFAP.  The  proportion of O-2A 
lineage  cells  that  differentiated 
into  GC  ÷  oligodendrocytes  was 
determined and compared to that 
seen when the cells were cultured 
on PDL alone. More than 95 % of 
the O-2A lineage cells were GC  + 
when  cultured  on  PDL  alone. 
In this and the following figure, 
ECM was prepared from 9-12-d- 
old cultures,  and the results  are 
expressed as  means  +  SE of at 
least three experiments. ON, op- 
tic nerve. 
Lillien et al. ECM-associated  Astrocyte-inducing Signals  639 Table V. Cellular Sources of  the Nondiffusible Type-2 Astrocyte-inducing Signal 
Substratum 
O-2A lineage cells 
O-2A lineage  expressing a type-2 
cells expressing  astrocyte phenotype 
a type-2 astrocyte  after 3 d compared 
phenotype  with that seen with 
after 3 d  9-12 d ON ECM 
ECM from newborn ON cells 
+  9-12 d  in vitro 
ECM  from newborn ON cells 
+  4dinvitro 
Newborn ON cells  +  12 d  in vitro 
ECM  from non-O-2A lineage 
cells of newborn ON 
ECM  from meningeal ceils 
ECM  from type-1  astrocytes 
ECM  from meningeal macrophages 
ECM  from oligodendrocytes 
ECM  from oligodendrocytes plus 
O-2A progenitor cells 
Matrigel 
ECM  from bovine aortic 
endothelial cells 
63  ±  6  100 
4±1  7 
89  -i-  1  140 
53  +  3  110 
42  ±  4  95 
0  0 
0  0 
0  0 
0  0 
0  0 
72 +  10  104 
Enriched O-2A progenitor cells were grown in the presence of CNTF on PDL, ECM prepared from various types of cells, or on unextracted cultures of newborn 
optic nerve cells. Except where indicated,  ECM was prepared from 9-12-d-old cultures. After 3 d, the cells were triple-labeled  for C.,C, A2BS, and GFAP and 
the proportion of O-2A lineage cells that differentiated  into A2B5  +, GFAP  + type-2 astroeytes was determined and compared with that seen with cells cultured 
in CNTF on ECM prepared from 9-12-d-old cultures of newborn optic nerve cells, which varied between 35 and 93% in different experiments. ON, optic nerve. 
Not All Cell 7)Jpes Make the Relevant 
ECM-associated Molecules 
In the experiments described so far, ECM was prepared from 
newborn optic nerve cell cultures that were maintained, with 
or without PDGE in the absence of serum for 9-15 d (the 
presence or absence of PDGF did not affect the activity of 
the ECM [not shown]). ECM prepared from similar cultures 
but after only 3-4 d in vitro was much less effective in induc- 
ing stable type-2 astrocyte differentiation (Table V). Intact 
cells from  12 d-old cultures of newborn optic nerve cells 
(which were grown without PDGF and, therefore, did not 
contain type-2 astrocytes) were at least as effective as the 
ECM prepared from such cultures (Table V); in these cul- 
tures, many of the type-2 astrocytes that developed after the 
addition of enriched O-2A progenitor cells did not appear to 
be in contact with other cells, suggesting that the nondiffusi- 
ble signalling molecules are associated with the ECM and 
not just with cell surfaces. This finding also suggests that the 
active components in the ECM are normally extracellular 
and not merely released from intraceUular sites as a result 
of the cell removal procedure used to prepare the ECM. 
To begin to identify the cellular source(s) of the ECM- 
associated molecules, we first eliminated the O-2A lineage 
population from newborn optic nerve cells by treatment with 
A2B5 and anti-GC antibodies in the presence of rabbit com- 
plement.  ECM prepared from such cultures of non-O-2A 
lineage cells was as active as that prepared from cultures of 
unfractionated newborn optic nerve cells (Table V).  This 
non-O-2A lineage population contains mainly type-1 astro- 
cytes and meningeal cells, but also some endothelial cells 
and macrophages. When cultures enriched for specific types 
of  non-O-2A lineage cells were tested, ECM from meningeal 
cells was found to support stable type-2 astrocyte differentia- 
tion in the presence of CNTF, whereas ECM from cultures 
of cortical type-1 astrocytes (Tables IV and V) or of menin- 
geal macrophages (Table V) was  not effective. ECM pre- 
pared from cultures enriched for O-2A lineage cells (either 
oligodendrocytes or oligodendrocytes plus O-2A progenitor 
cells) were also ineffective, as was Matrigel, an ECM prepa- 
ration from mouse sarcoma cells (Table V). ECM prepared 
from cultures of multiply passaged bovine aortic endothelial 
cells was as effective as ECM from meningeal cultures and 
newborn optic nerve cells (Table V). These results suggest 
that the  ECM-associated  molecules that  collaborate with 
CNTF to induce type-2 astrocyte development are made by 
nonglial cells. 
ECM-associated Molecules Inhibit Oligodendrocyte 
Differentiation Even in the Absence of CNTF 
In all of  the cases we tested, ECM did not induce type-2 astro- 
cyte differentiation unless CNTF was added to the cultures 
(see Table IZI, for example). All of the ECMs that collabo- 
rated with CNTF to induce type-2 astrocyte differentiation, 
however,  inhibited the differentiation of O-2A progenitor 
cells into oligodendrocytes even without the addition of CNTE 
Whereas in the absence of ECM >95 % of O-2A progenitor 
cells differentiated into GC  ÷ oligodendrocytes within 3 d in 
vitro (Fig. 2 a), in the presence of ECM prepared from optic 
nerve cultures (and in the absence of CNTF), <30 % of  O-2A 
progenitor cells differentiated into oligodendrocytes within 
3 d (Fig. 2 c). ECM made by meningeal cells and endothelial 
cells also inhibited oligodendrocyte differentiation (Fig. 2, e 
and f), whereas ECM prepared from type-1 astrocyte cul- 
tures did not (Fig. 2 g). CNTF, in the absence of ECM, did 
not inhibit oligodendrocyte differentiation (Fig. 2 b). 
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treated 
ECM  ECM  Cultured 
treated  incubated  for 3 d 
Substratum  with  for 3 h with  with 
(a)  ON ECM  untreated  CNTF 
(b)  ON ECM  0.5 M  NaCI  CNTF 
(c)  ON ECM  1 M  NaCI  CNTF 
(d)  ON ECM  2 M  NaCI  CNTF 
(e)  ON ECM  2 M  NaCI  2M-ONE  CNTF 
(f)  PDL  2M-ONE + CNTF 
(g)  ON ECM  2 M  NaCI  2M-ONE + CNTF 
(h)  Matrigel  2M-ONE + CNTF 
(i)  Type-I  2 M NaCI  2M-ONE + CNTF 
astrocyte 
ECM 
(j)  ON ECM  2 M  NaCI  CNTF 
(k)  ON ECM  2 M  NaCI  bFGF + CNTF 
% O-2A lineage cells expressing 
a type-2 astrocyte phenotype 
after 3 d compared to that seen 
with ON EC, M plus CNTF 
25  50  75  100 
l 
I 
Figure 3.  Removing and  recon- 
stituting ECM-associated signals 
that induce type-2 astrocyte dif- 
ferentiation  in  the  presence  of 
CNTE Enriched O-2A progeni- 
tor cells were cultured for 3 d and 
then either double-labeled for GC 
and  GFAP or triple-labeled  for 
GC, A2B5, and GFAE The pro- 
portion of O-2A lineage cells that 
differentiated  into  cells  with  a 
type-2 astrocyte phenotype (pro- 
cess-bearing ceils that were either 
A2B5  +, GFAP  +, or GC-, GFAP  +) 
was  determined  and  compared 
with that seen with cells cultured 
on ON ECM (prepared from 9- 
12-d-old cultures of newborn op- 
tic nerve cells) in the presence of 
CNTF, which varied between 35 
and 93 % in different experiments. 
ECM Activity Is Removed by Treatment with 2 M NaCI 
To begin to characterize the signaling molecules associated 
with the ECM made by optic nerve cell cultures, we tried to 
remove the molecules by treating the ECM with increasing 
concentrations of NaC1. Whereas treatment with 0.5 M NaCI 
had little if any effect (Fig. 3 b), treatment with 1 M NaC1 
removed approximately half of the type-2 astrocyte-inducing 
activity (Fig. 3 c), but had no effect  on the ability of the ECM 
to inhibit oligodendrocyte differentiation (Fig. 2 h). Treat- 
ment with 2  M  NaCI removed 60-80%  of both activities 
(Figs. 2 j  and 3 d), as did 3 M NaCI (not shown). Both the 
type-2 astrocyte-inducing (Fig.  3  e)  and oligodendrocyte- 
inhibiting activities (Fig. 2 k) were restored if the salt-treated 
ECM was  incubated with an extract of optic nerves from 
3--4-wk-old rats made in 2 M NaC1. This optic nerve extract 
(2M-ONE) did not induce stable type-2 astrocyte differentia- 
tion when applied in the absence of the 2 M  NaCl-treated 
ECM,  even in the presence of extra CNTF (Fig.  3 f), al- 
though it did inhibit oligodendrocyte differentiation in the 
absence of  ECM (Fig. 21). Thus type-2 astrocyte differentia- 
tion  requires  the  combination of CNTF  and  2  M  NaC1- 
extractable molecules in ECM, which must either be bound 
to the ECM to act or be presented in combination with an 
additional  ECM-associated signal  that is not extracted by 
2 M NaC1.  Surprisingly, 2M-ONE was not able to activate 
either Matrigel or ECM prepared from cultures of type-1 as- 
trocytes to collaborate with CNTF to induce type-2 astrocyte 
differentiation (Fig. 3, h and i). 2 M NaCl-treated type-1 as- 
trocyte ECM, however, could be activated by 2M-ONE to in- 
hibit oligodendrocyte differentiation (Fig. 2 m). CNTF itself 
did not bind in an active form to ECM prepared from optic 
nerve cultures, whether or not the ECM was first treated with 
2 M NaCI (Fig. 3j), excluding the possibility that the ECM 
acts simply to concentrate or present CNTF to O-2A progen- 
itor cells. 
If 2 M NaCl-treated ECM prepared from optic nerve cul- 
tures was incubated in 100 ng/ml of bFGE its ability to in- 
hibit  oligodendrocyte  differentiation  was  completely  re- 
stored (Fig. 2 n). This concentration of bFGF, however, did 
not restore the ability of salt-washed ECM to collaborate 
with CNTF in inducing type-2 astrocyte differentiation, even 
when  the  bFGF  was  continuously present in  the  culture 
(Fig. 3 k). 
Discussion 
Previous studies suggested that CNTF is only one part of a 
system of extraeellular inducing signals required for the de- 
velopment of type-2 astrocytes (Hughes et al., 1988; Lillien 
et al., 1988). We have now shown that O-2A progenitor cells 
can be induced to differentiate in vitro into stable type-2 as- 
trocytes by a combination of CNTF and a nondiffusible sig- 
nal that is associated with the extracellular matrix produced 
by cultures of  optic nerve cells. Single-cell experiments indi- 
cate that both signals act directly on O-2A progenitor cells. 
The ECM-associated signal has two effects on O-2A progen- 
itor cells: it promotes type-2 astrocyte differentiation, and it 
inhibits  oligodendrocyte differentiation. Whereas  the  first 
effect requires CNTF, the second does not. 
~ming Mechanism of ~e-2 Astrocyte Development 
The development of O-2A progenitor cells into oligodendro- 
cytes appears not to require environmental inducing signals 
(Temple and  Raft,  1985).  Both the choice and timing  of 
oligodendrocyte development seem to depend instead on an 
intrinsic mechanism that limits progenitor cell proliferation 
in  response  to  PDGF;  oligodendrocyte differentiation is 
thought to follow automatically as a consequence of the pro- 
genitor cell's  withdrawal  from the cell cycle (Raft et al., 
1988; Hart et al.,  1989). 
Type-2 astrocytes, like oligodendrocytes, begin to differ- 
entiate on a predictable schedule both in vivo (Miller et al., 
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1985; Lillien et al., 1988; Lillien and Raft, 1990). In princi- 
ple, the timing of type-2 astrocyte development could reflect 
the timed production of inducing signals (environmental con- 
trol),  the timed responsiveness to these signals (intrinsic 
control), or both.  Previous work demonstrated that O-2A 
progenitor cells can respond prematurely, although transiently, 
to CNTF (Hughes et al., 1988). In this study we have shown 
that perinatal O-2A progenitor cells can respond to the com- 
bination of CNTF and ECM by differentiating into stable 
type-2 astrocytes at least a week before they normally would 
do so in vivo. This combination of type-2 astrocyte-inducing 
signals is not inhibited by PDGF, although, in the absence 
of  exogenous ECM, PDGF antagonizes the transient response 
to  CNTF.  These and previous observations (Hughes and 
Raft, 1987; Hughes et al., 1988; Lillien et al., 1988; Lillien 
and Raft, 1990) suggest that O-2A progenitor cells are respon- 
sive  to  type-2 astrocyte-inducing signals before the cells 
reach an intrinsic proliferation limit and that the timing of 
type-2 astrocyte development depends exclusively on when 
the inducing signals appear. In previous studies it was shown 
that the production of CNTF in the developing optic nerve 
(Hughes et al., 1988) and in cultures of brain ceils (Lillien 
et al., 1988) coincides with the development of type-2 astro- 
cytes. In this study we found that the signal associated with 
the ECM also increases with time in cultures of newborn op- 
tic nerve cells. It is not clear whether this increase results 
from the timed production of the signal or from the steady 
accumulation of the signal with time in vitro; in either case, 
it probably contributes to the timing of type-2 astrocyte de- 
velopment in optic nerve cultures. We have not yet deter- 
mined when the ECM-associated signal first appears in the 
developing optic nerve. 
Cellular Source of the ECM-associated Signal 
The differentiation of O-2A progenitor cells into type-2 as- 
trocytes in vitro was previously shown to require non-O-2A 
lineage cells (Lillien and Raft, 1990),  which, in optic nerve 
cultures, include type-1 astrocytes, meningeal cells, macro- 
phages, and endothelial cells. This observation is now ex- 
plained as non-O-2A lineage cells appear to be the source 
of both CNTF and the ECM-associated signal, at least in 
vitro.  Type-1  astrocytes  were  previously  shown  to  be  a 
source ofCNTF (Lillien et al., 1988), but this study suggests 
that they do not make the ECM-associated inducing signal: 
ECM produced by cultures of cortical type-1 astrocytes did 
not induce type-2 astrocyte differentiation in the presence of 
CNTE Whereas ECM produced by cultures of macrophages 
or O-2A lineage cells was also ineffective at inducing type-2 
astrocyte development in the presence of CNTF, ECM pro- 
duced by cultures of cerebral meningeal cells or bovine aor- 
tic endothelial cells was as effective as ECM produced by 
cultures of mixed optic nerve ceils. The meningeal cultures 
were morphologically heterogeneous and might well have 
contained endothelial cells, as the meninges used to prepare 
the cultures were rich in blood vessels. It remains to be de- 
termined whether CNS endothelial cells also produce the 
ECM-associated type-2 astrocyteinducing  signal, and whether 
these ceils are the source of the signal in vivo. As meningeal 
cultures were found previously not to produce CNTF-like 
activity (Lillien et al., 1988), it seems that at least two types 
of non-O-2A lineage cells must collaborate to induce type-2 
astrocyte development in vitro. 
Nature of the ECM-associated  Signal 
There are numerous reports of the influence of ECM compo- 
nents on the growth and differentiation of a variety of cell 
types; some of these effects are mediated by the structural 
components of the ECM itself (for example, Panayotou et 
al., 1989; Adams and Watt, 1989), whereas others are medi- 
ated by signalling molecules bound to the ECM (for exam- 
ple, Vlodavsky et al., 1987; Baird and Ling, 1987; Gordon 
et al., 1987; Rogelj et al., 1989). The functional significance 
of ECM-bound signaling molecules is not clear. In the case 
of bFGF, which is active in a soluble state, association with 
the ECM has been reported to stabilize the protein (Gospo- 
darowicz and Cheng, 1986; Saksela et al., 1988), and it has 
been suggested that ECM might serve as a storage site for 
FGF (Baird and Ling, 1987; Vlodavsky et al., 1987). Treat- 
ment of ECM with high concentrations of NaCI causes bound 
factors such as bFGF to dissociate (Baird and Ling, 1987; 
Vlodavsky et al., 1987),  and it might also release some in- 
trinsic matrix components as well (for example, Lindahl and 
H66k, 1978; Timpl and Rohde, 1979). Although we refer to 
the nondiffusible signal that influences O-2A progenitor cell 
development as ECM associated, many ECM-associated mol- 
ecules are also bound to cell surfaces, and we cannot exclude 
the possibility that the nondiffusible signal we have studied 
is also cell-surface associated. We found that when O-2A 
progenitor cells were grown (in the presence of CNTF) on 
12-d-old  cultures of newborn optic nerve cells, rather than 
on ECM prepared from such cultures, many of  the type-2 as- 
trocytes that developed were located entirely on the substra- 
tum between the optic nerve cells. This finding suggests that 
the nondiffusible signal that collaborates with CNTF to in- 
duce type-2 astrocyte differentiation is not exclusively asso- 
ciated with cell surfaces. By contrast, studies ofa nondiffusi- 
ble signal made by 3T3 cells that stimulates the proliferation 
and development of hemopoeitic stem ceils have shown that 
the stem cells respond only when in contact with the 3T3 
cells and not when located on the ECM produced by these 
cells (Roberts et al.,  1987). 
To begin to characterize the ECM-associated molecules 
that inhibit oligodendrocyte differentiation and act in con- 
junction with CNTF to induce type-2 astrocyte differentia- 
tion, we treated ECM made by optic nerve cultures with 2 M 
NaCI. This treatment largely removed both the type-2 astro- 
cyte-inducing activity and the oligodendroeyte differentia- 
tion inhibiting activity. Both activities were restored by incu- 
bation of the salt-treated ECM with an extract of optic nerve 
made in 2 M NaC1. This finding suggests that the nondiffusi- 
ble signal, like CNTF (Hughes et al.,  1988),  is present in 
the optic nerve at the time type-2 astrocytes are developing. 
Does  the  same  ECM-associated molecule both  induce 
type-2 astrocyte differentiation and inhibit oligodendrocyte 
differentiation? Four findings suggest that the two activities 
are mediated by different molecules. (a) When ECM pro- 
duced by cultures of newborn optic nerve cells was treated 
with 1 M NaC1, much more type-2 astrocyte-inducing activ- 
ity was removed than oligodendrocyte-inhibiting  activity. (b) 
The active component(s) in 2 M NaCI extracts of optic nerve 
appears to have to be associated with ECM to induce type-2 
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differentiation. (c)  The  addition of bFGF to 2  M  NaC1- 
washed ECM reconstituted the ability of the ECM to inhibit 
oligodendrocyte  differentiation, but it did not reconstitute the 
ability of  the ECM to collaborate with CNTF to induce type- 
2 astrocyte differentiation. (d) Whereas ECM made by type- 
1 astrocyte cultures expressed neither activity, treatment of 
this ECM with 2 M NaC1 extracts of optic nerve conferred 
oligodendrocyte inhibiting activity but not type-2 astrocyte- 
inducing activity. A  parsimonious interpretation of these 
findings is that bFGF, or a related protein, is responsible for 
the oligodendrocyte inhibitory effect of the ECM while a 
different molecule is responsible for the type-2 astrocyte- 
inducing effect. Preliminary observations indicate that the 
ECM-associated type-2 astrocyte-inducing activity is sensi- 
tive to trypsin but not to collagenase, suggesting that the rele- 
vant signaling molecule is itself  a noncollagenous protein, or 
is bound to such a protein. 
Mechanism of  Action of 
the ECM-associated Molecules 
The presence of ECM appears to change the response of 
perinatal O-2A progenitor cells to CNTF from a transient 
to a stable one. Several observations, however,  suggest that 
even the transient response to CNTF requires some ECM. 
When  enriched  O-2A  progenitor  cells  were  exposed  to 
CNTF for 24 h, few responded in the absence of ECM, al- 
though many responded in the presence of ECM. By con- 
trast, 20-30%  of the O-2A progenitor cells in cultures of 
newborn optic nerve responded transiently to CNTF in the 
absence of  exogenous ECM, although many more responded 
in the presence of ECM. As newborn optic nerve cultures 
contain a high proportion of non-O-2A lineage cells (Lillien 
and Raft, 1990), which are the source of  the ECM-associated 
signals, it is possible that these ceils produce enough ECM 
to support a transient response to CNTF but not enough to 
support a stable response. A correlation between the propor- 
tion of  non-O-2A lineage cells present and the degree of  tran- 
sient response to CNTF was observed previously (although 
its significance was not recognized): the transient response 
to CNTF was found to be lower in cultures of P7 optic nerve 
cells, which contain relatively few non-O-2A lineage cells, 
than in cultures of perinatal optic nerve cells, which contain 
many such cells (Hughes and Raft, 1987). 
There  are  other  instances  where  the  combination  of 
diffusible and  non-diffusible extracellular signals  are  re- 
quired for a cellular response. For example, the response of 
blood  neutrophils  to  tumor  necrosis  factor  requires  an 
integrin-mediated interaction with ECM proteins (Nathan et 
al.,  1989),  and the survival of embryonic sensory neurons 
in vivo is promoted by the combination of brain-derived neu- 
rotrophic factor and laminin, but not by brain-derived neuro- 
trophic factor alone (Kalcheim et al.,  1987).  In neither of 
these cases is the mechanism of the collaboration under- 
stood. Similarly, it is not clear how CNTF and the ECM- 
associated molecules collaborate to induce type-2 astrocyte 
development, although it is clear that the ECM does not sim- 
ply bind CNTF and present it to O-2A progenitor cells, as 
we could not detect CNTF activity in ECM even after the 
ECM was treated with exogenous CNTE  Our finding that 
ECM inhibits oligodendrocyte differentiation but does not 
induce type-2 astrocyte development in the absence of CNTF 
demonstrates that the inhibition of the default pathway of 
O-2A progenitor cell development is not sufficient on its own 
to induce type-2 astrocyte differentiation; positive inducing 
signals are still required. It is possible, however, that the in- 
hibition of oligodendrocyte  differentiation is an essential part 
of the induction process. 
The most important conclusion of this study is that both 
CNTF and ECM-associated molecules are required to in- 
duce O-2A progenitor ceils to develop into type-2 astrocytes 
in serum-free cultures. It is not known whether, in inducing 
stable type-2 astrocyte development in vitro, FCS mimics 
the effects of these diffusible and nondiffusible signals, or 
whether  it  induces their  production or  release;  previous 
single-cell experiments suggest that FCS can act both directly 
and indirectly on progenitor cells to induce them to differen- 
tiate into type-2 astrocytes (Temple and Raft, 1985). It is also 
uncertain how our findings in vitro relate to glial cell differ- 
entiation in vivo; it is clear, however,  that both signals re- 
quired for type-2 astrocyte development in vitro are present 
in the optic nerve at the time type-2 astrocytes are thought 
to be developing. 
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